![Michel Kaczorek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michel Kaczorek joined Synt:em SA in 1995 and currently serves as President.
He is a Director of CliniGenetics SA.
Postes actifs de Michel Kaczorek
| Sociétés | Poste | Début |
|---|---|---|
Synt:em SA
 Synt:em SA Pharmaceuticals: MajorHealth Technology Researches and manufactures drugs for the treatment of pain and cancer | Directeur Général | 01/01/1995 |
Anciens postes connus de Michel Kaczorek
| Sociétés | Poste | Fin |
|---|---|---|
CliniGenetics SA
 CliniGenetics SA Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Researches and manufactures drugs for the treatment of pain and cancer | Health Technology |
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases | Health Technology |
